Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Carboplatin and alpha-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot studyG Frasci, A Tortoriello, G Facchini, et al.Gynecologic Oncology|July 1, 1993
Intraperitoneal (ip) cisplatin-mitoxantrone-interferon-alpha 2b in ovarian cancer patients with minimal residual diseaseG Frasci, A Tortoriello, G Facchini, et al.Minerva Chirurgica|May 10, 2003
[Endoscopic palliative treatment of the common bile duct at the hepatic hilum. Results in 583 patients treated in a single center over a 10-year period]G D De Palma, F Persico, S Masone, et al.Cancer|March 15, 1996
A risk model for ovarian carcinoma patients using CA 125: time to normalization renders second-look laparotomy redundantG Frasci, S Conforti, F Zullo, et al.Surgical Endoscopy|June 1, 1996
Laparoscopic cholecystectomy (LC), intraoperative endoscopic sphincterotomy (ES), and common bile duct stones (CBDS) extraction for management of patients with cholecystocholedocholithiasisG D De Palma, L Angrisani, M Lorenzo, et al.Biology of Reproduction|February 1, 1997
Expression of vascular endothelial growth factor and placenta growth factor in human placentaP Vuorela, E Hatva, A Lymboussaki, et al.Genomics|September 1, 1987
Molecular studies of marsupial X chromosomes reveal limited sequence homology of mammalian X-linked genesD C Kaslow, B R Migeon, M G Persico, et al.Minerva Chirurgica|July 15, 2004
[Endoscopic palliation of inoperable hilar biliary carcinoma with self-expanding metal stents]G D De Palma, M Rega, M Persico, et al.Nucleic Acids Research|December 21, 1984
Complete concordance between glucose-6-phosphate dehydrogenase activity and hypomethylation of 3' CpG clusters: implications for X chromosome dosage compensationS F Wolf, S Dintzis, D Toniolo, et al.Breast Cancer Research and Treatment|August 1, 1995
Mitoxantrone plus vinorelbine with granulocyte-colony stimulating factor (G-CSF) support in advanced breast cancer patients. A dose and schedule finding studyG Frasci, G Comella, P Comella, et al.Pageof 11